Magnetar Financial’s Cullinan Oncology CGEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-26,263
Closed -$156K 963
2025
Q3
$156K Buy
+26,263
New +$192K ﹤0.01% 795

Other funds holding CGEM

Magnetar Financial's CGEM Position: Q4 2025 in Review

Magnetar Financial sold out of Cullinan Oncology (CGEM) in Q4 2025, closing a stake of 26,263 shares — an estimated $156K sold.

Magnetar Financial first reported a position in CGEM in Q3 2025 and held it in 1 quarter. The position peaked at $156K in Q3 2025. 153 funds tracked by Wall St. Rank hold CGEM as of Q4 2025.

  • Magnetar Financial reported no remaining Cullinan Oncology position as of Q4 2025 after selling out during the quarter.
  • Magnetar Financial sold 26,263 Cullinan Oncology shares in Q4 2025, an estimated $156K.
  • Magnetar Financial first reported a position in Cullinan Oncology in Q3 2025 and held it in 1 quarter.
  • Magnetar Financial's Cullinan Oncology position peaked at $156K in Q3 2025.
  • 153 funds tracked by Wall St. Rank held Cullinan Oncology as of Q4 2025.

Based on Magnetar Financial's 13F filing for Q4 2025, filed 17 Feb 2026.